(2R,5R)-1-[4-(3-Fluoro-2-methyl-benzyloxy)-benzenesulfonyl]-5-hydroxy-3,3-dimethyl-piperidine-2-carboxylic acid hydroxyamide

ID: ALA189216

PubChem CID: 44399712

Max Phase: Preclinical

Molecular Formula: C22H27FN2O6S

Molecular Weight: 466.53

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1c(F)cccc1COc1ccc(S(=O)(=O)N2C[C@H](O)CC(C)(C)[C@@H]2C(=O)NO)cc1

Standard InChI:  InChI=1S/C22H27FN2O6S/c1-14-15(5-4-6-19(14)23)13-31-17-7-9-18(10-8-17)32(29,30)25-12-16(26)11-22(2,3)20(25)21(27)24-28/h4-10,16,20,26,28H,11-13H2,1-3H3,(H,24,27)/t16-,20+/m1/s1

Standard InChI Key:  QEWCDBOSGBDOOY-UZLBHIALSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  1  0  0  0  0  0999 V2000
    2.9542   -2.3500    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.9542   -3.1792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2417   -3.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2375   -4.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5250   -3.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6792   -3.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9625   -1.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7792   -2.3417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -2.3417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1292    1.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9542   -4.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5292   -2.3542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6750   -4.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4125    0.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8375    0.9333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8125   -3.5875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7042    1.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2542   -1.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6792   -1.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9792    0.9583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9792    0.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5542    1.3458    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2292   -5.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4125   -4.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6875   -0.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2542   -0.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0917   -3.1750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3875   -4.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1125   -0.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1292    2.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4042    0.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8292    0.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  3  5  1  6
  6  2  1  0
  7  1  1  0
  8  1  2  0
  9  1  2  0
 10 14  1  0
 11 13  1  0
 12  5  2  0
 13  6  1  0
 14 17  1  0
 15 10  2  0
 16  5  1  0
 17 20  1  0
 18  7  2  0
 19  7  1  0
 20 21  1  0
 21 25  1  0
 22 15  1  0
 23  4  1  0
 24  4  1  0
 25 19  2  0
 26 18  1  0
 27 16  1  0
 13 28  1  6
 29 31  1  0
 30 10  1  0
 31 14  2  0
 32 29  2  0
 26 21  2  0
 11  4  1  0
 32 15  1  0
M  END

Associated Targets(Human)

MMP13 Tchem Matrix metalloproteinase 13 (4133 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cell line (371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADAMTS4 Aggrecanase (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 466.53Molecular Weight (Monoisotopic): 466.1574AlogP: 2.37#Rotatable Bonds: 6
Polar Surface Area: 116.17Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.71CX Basic pKa: CX LogP: 2.65CX LogD: 2.63
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -0.72

References

1. Noe MC, Natarajan V, Snow SL, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Carty TJ, Barberia JA, Sweeney FJ, Liras JL, Vaughn M, Hardink JR, Hawkins JM, Tokar C..  (2005)  Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.,  15  (11): [PMID:15911259] [10.1016/j.bmcl.2005.03.105]
2.  (2001)  Selective inhibitors of aggrecanase in osteoarthritis treatment,